HS GET Symposium & Discussion Series - Do Innovative Instruments Deliver More Money for Global Health?

Sponsored by
Health Systems GET
of the Health, Nutrition and Population Sector of the Human Development Network

HS GET Symposium & Discussion Series

Do Innovative Financing Instruments Deliver
More Money for Global Health?

In September 2009 the High Level Taskforce on Innovative International Financing for Health Systems announced a series of new financing mechanisms in an effort to raise ‘More Money for Health’. These include an expanded International Financing Facility for Immunization, exploring Advance Market Commitments, and Voluntary Contributions made when purchasing airline tickets. Around this year’s MDG summit in New York, global leaders called for more innovative financing mechanisms including taxes on financial transactions. On October 19 the Health Systems GET hosted a discussion on the experience so far with innovative financing mechanisms – has more money been raised for health systems? Are they worth the trouble to set up?

To access a video of the discussion click HERE.

To access the two powerpoint presentations, click on the icon after the presentation name below.

GAVI Alliance and International Finance Facility for Immunisation

Innovative Financing for Development - A World Bank Perspective

Tuesday, October 19, 2010
8:00 - 10:00 a.m.
JB1-075

Presenters
David Ferreira
Managing Director for Innovative Finance, GAVI Alliance
Susan McAdams
Director, Multilateral Trusteeships & Innovative Finance, World Bank

Discussants
Robert Hecht
Principal and Managing Director, Results for Development
Mario Mansour
Senior Economist, Tax Policy Division, Fiscal Affairs Department, IMF

Chair
Armin Fidler
Advisor, Health Policy and Strategy, World Bank

In September 2009 the High Level Taskforce on Innovative International Financing for Health Systems announced a series of new financing mechanisms in an effort to raise ‘More Money for Health’  (http://www.internationalhealthpartnership.net/en/taskforce). These include an expanded international Financing Facility for Immunization, exploring Advance Market Commitments and Voluntary Contributions made when purchasing airline tickets. Around this year’s MDG summit in New York, global leaders called for more innovative financing mechanisms including taxes on financial transactions.
http://www.english.rfi.fr/americas/20100921-france-champions-innovative-financing-development;

For Discussion – experience so far on innovative financing mechanisms – has more money been raised for health systems?
Are they worth the trouble to set up?
Are Tobin Taxes the next big thing?

For an overview of innovative financing mechanisms take a look at the attached Glossary.
Glossary_Innovative_Financing_October_2009.pdf 

David Ferreira is the Managing Director for Innovative Finance, for the GAVI Alliance and is also the head of GAVI's Washington DC office. Prior to joining GAVI in March 2010, David Ferreira was the founding investment manager of Soul City Broad-Based Empowerment Company, an investment company owned by the South African non-profit organization Soul City Institute for Health and Development Communication. David was a founding shareholder and director of Praxis Capital, a private equity business focused on South Africa’s healthcare and education sectors. Before Praxis, David's background was largely in project and corporate finance.
http://www.gavialliance.org/

Susan McAdams heads the World Bank department responsible for multilateral innovative financing initiatives, and for financial management and trust administration of multilateral development funds. She led the World Bank’s engagement in the design, negotiation and implementation of the International Finance Facility for Immunization and the pilot Advance Market Commitment for vaccines against pneumococcal diseases.
Concessional Finance and Global Partnerships - http://go.worldbank.org/QQ05TVMVE0

Robert Hecht joined Results for Development in April 2008, and is currently managing a growing portfolio of projects analyzing policy barriers and solutions related to AIDS and health financing and improving R&D and access to new health technologies in developing countries. Before coming to Results for Development, he spent four years as vice president for Policy and Advocacy at the International AIDS Vaccine Initiative. Prior to this, he had a 20 year tenure at the World Bank, where he occupied a number of senior posts including manager of the Bank's central unit for Health, Nutrition, and Population.
http://www.resultsfordevelopment.org/

Mario Mansour is a Senior Economist in the Tax Policy Division of the IMF Fiscal Affairs Department. He leads tax advisory missions and undertakes research on policy practices in IMF member countries. Prior to joining the IMF, Mr. Mansour worked for a Canadian consultancy from 2000 to 2004, where he played a lead role in tax reform projects in the Middle East and Eastern Caribbean island economies. From 1992 to 2000, Mr. Mansour worked as an Economist at the Canadian Department of Finance.

Armin Fidler joined the World Bank in 1993 in the Latin America and Caribbean (LAC) Region. He moved to the Europe and Central Asia Region in 1997 and became Manager for Health, Nutrition, Population, responsible for the Bank’s health strategy, lending and technical assistance, including analytical and advisory work in the European Union, the New Member States and the countries of the former Soviet Union. In 2008 Dr. Fidler became Advisor for Health Policy and Strategy in the Bank’s Human Development Network, responsible for global health policy, international health partnerships, Health Reform in Middle Income Countries and cross-cutting "Health in All Policies", such as in the areas of Climate Change, Water and Sanitation or Road Traffic Injuries.